Is D5 (dextrose 5%) effective in correcting hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

D5 (Dextrose 5%) Does NOT Correct Hypotension

D5 (5% dextrose in water) should not be used to correct hypotension, as it functions as a hypotonic solution in vivo and can actually worsen hemodynamic instability and increase intracranial pressure. 1

Why D5 Fails as a Resuscitation Fluid

Physiological Problem with D5

  • D5 behaves as free water in the body because glucose is rapidly metabolized, leaving behind hypotonic fluid that shifts from the extracellular space into cells 1
  • While D5 appears isotonic in vitro (approximately 252 mOsmol/L), its in vivo effect is equivalent to pure water once dextrose is metabolized 1
  • This hypotonic effect can decrease plasma osmolality by 3%, producing dangerous increases in intracranial pressure of approximately 15 mmHg 1

Appropriate Fluid Choices for Hypotension

For initial resuscitation of hypotensive patients, crystalloids (normal saline or lactated Ringer's) should be used first, with colloids added within prescribed limits for each solution. 2

Crystalloid Solutions (First-Line)

  • Normal saline (0.9% NaCl) is the preferred initial fluid for treating hypotension, as it maintains appropriate osmolality (286 mOsmol/kgH2O) 1
  • Crystalloids should be infused rapidly to restore mean arterial pressure to 65-70 mmHg 2
  • Large volumes may be required: adults can receive 1-2 L at 5-10 mL/kg in the first 5 minutes; children can receive up to 30 mL/kg in the first hour 2

When D5-Containing Solutions Are Used

  • D5 normal saline (D5NS) contains both dextrose and sodium chloride and may be used as a vehicle for vasopressor administration 3
  • However, the primary therapeutic effect comes from the saline component, not the dextrose 3
  • The dextrose content (50 grams per liter) must be considered in patients with diabetes or glucose metabolism disorders 3

Evidence-Based Fluid Selection

Trauma and Hemorrhagic Shock

  • Hypertonic saline (3% or 7.5%) has shown benefit in increasing blood pressure in trauma patients, though effects may not be sustained beyond the first hour 2
  • The SAFE study showed albumin was not superior to normal saline, with a trend toward higher mortality in trauma patients receiving albumin (p = 0.06) 2

Septic Shock

  • Norepinephrine is the first-line vasopressor for correcting hypotension in septic shock, not fluid alone 2
  • Fluid resuscitation should be achieved within 3 hours, using crystalloids as first choice 2
  • Avoid fluid overload, which can aggravate gut edema and increase intra-abdominal pressure 2

Special Populations

Pediatric Patients

  • For hypotension refractory to volume replacement, dopamine can be administered at 2-20 mcg/kg/min (prepared using "rule of 6": 0.6 × body weight in kg = mg diluted to 100 mL saline) 4
  • Epinephrine remains the primary intervention for anaphylaxis-related hypotension 2

Geriatric Patients

  • Isotonic fluids (not D5) should be used for volume depletion via oral, subcutaneous, or intravenous routes 2
  • For low-intake dehydration (osmolality >300 mOsm/kg), hypotonic fluids are appropriate, but this represents a different clinical scenario than acute hypotension 2

Critical Pitfalls to Avoid

  • Never use D5W as a primary resuscitation fluid for hypotension—it provides no sustained volume expansion and can cause cellular edema 1
  • Avoid confusing D5W with D5NS; the latter contains sodium and provides some volume expansion from the saline component 3
  • Large volumes of hypotonic solutions can increase intracranial pressure and should be avoided in patients at risk for cerebral edema 1
  • When epinephrine infusions are prepared in D5W for anaphylaxis management, the therapeutic effect comes from epinephrine, not the dextrose carrier solution 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dextrose Content in IV Fluids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dopamine Administration in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.